Company Filing History:
Years Active: 2022
Title: The Innovations of Anne Stephenson
Introduction
Anne Stephenson is a notable inventor based in Cambridge, GB. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific diseases and disorders. Her work focuses on the modulation of neurotransmitter release, which is crucial for treating various medical conditions.
Latest Patents
Anne Stephenson holds a patent for "MGluR7 agonist compounds for treating mGluR7-regulated diseases, disorders, or conditions." This invention provides compounds of formula (I) and pharmaceutically acceptable salts, along with a process for their preparation. The patent outlines pharmaceutical compositions containing these compounds and their therapeutic uses. Specifically, it details methods for treating diseases associated with the glutamatergic and GABAergic signaling pathways regulated by metabotropic glutamate receptor 7 (mGluR7).
Career Highlights
Throughout her career, Anne has demonstrated a commitment to advancing medical science through her innovative research. She has been instrumental in developing therapies that address complex neurological conditions. Her work has the potential to improve the quality of life for many patients suffering from these disorders.
Collaborations
Anne collaborates with esteemed colleagues, including Martin Teall and Kathryn White. These partnerships enhance her research efforts and contribute to the success of her projects.
Conclusion
Anne Stephenson's contributions to the field of pharmaceuticals through her innovative patents and collaborations highlight her role as a leading inventor. Her work continues to pave the way for advancements in treating neurological diseases.